×
切換帳號
FAQ
新手指南
FAQ常見問題
學術會議
影音網
登入
×
全站搜尋
搜尋
台灣泌尿科醫學會E-School
登入
FAQ
新手指南
FAQ常見問題
學術會議
影音網
到官網
Home
到官網
Home
知識庫
目錄總覽
文件總覽
最新討論
目錄 / 資料夾
學術活動與演講
年會
2026半年會
摘要
2025年會 (UAA)
摘要
2025半年會
摘要
2024年會
摘要
2024半年會
摘要
2023年會
摘要
2023半年會
摘要
2022年會
摘要
2021年會
摘要
2021半年會
摘要
2020年會
摘要
2020半年會
摘要
2019年會
摘要
2019半年會
摘要
2018年會
摘要
2018半年會
摘要
2017年會
摘要
2017半年會
摘要
2016年會
摘要
2016半年會
摘要
2015年會
摘要
新手指南與FAQ
知識庫
最新上傳
最新上傳
(
熱門
)
最新上傳
(
熱門
)
#0699 Clinical study on the effect of corrective treatment and related factors in patients with penile curvature deformity
04-23
#0627 The risk factors and comorbidities associated with premature ejaculation in young men
04-23
#0571 Retrospective study on the treatment of penile curvature by penile plication combined with superficial suspensory ligament release
04-23
#0388 Optimizing Therapeutic Parameters for Low-Intensity Shockwave Therapy in Erectile Dysfunction—A Systematic Review and Meta-Analysis of Randomized Controlled Trials
04-23
#0365 A Potential Visual Indicator of Early Microvascular Damage in Patients with Erectile Dysfunction
04-23
#0354 Inflatable Penile Prosthesis Mechanical Failure Incidence and Pattern: A Single Australian Centre Experience
04-23
#0329 Comparative Study on Erectile Function in Patients with Benign Prostatic Hyperplasia and Prostate Cancer
04-23
#0306 Decreased Penile Hemodynamics Correspond with the Severity of Chronic Kidney Disease in Non-Diabetic Men with Erectile Dysfunction
04-23
#0147 EFFICACY OF PRP INTERVENTION ON POST CAVERNOUS NERVE INJURY-INDUCED ERECTILE DYSFUNCTION : META-ANALYSIS OF IN VIVO STUDY
04-23
#0128 Blood Metabolites as Mediators in Erectile Dysfunction: Insights from a Multi-Center Proteomics and Genetic Study
04-23
#1292 Management for Long Segment Stricture: A Systematic Review and Meta-Analysis
04-23
#1277 Minimally Invasive (Robotic vs 2D vs 3D Laparoscopic) Pyeloplasty: Experience at a Tertiary Care Centre
04-23
#0775 Urethral stricture recurrence after urethroplasty: an Australian multi-institution, single surgeon series
04-23
#0730 Treatment Outcomes of Patients with Hunner’s Interstitial Cystitis Who Received Augmentation Enterocystoplasty or Bladder-Preserving Therapy
04-23
#0714 Predictors of Progression to Alternate 3rd Line Overactive Bladder Treatment Following PTNS.
04-23
#0621 Optimal duration of hydrodistension for symptomatic treatment of interstitial cystitis: A systematic review and meta-analysis
04-23
#0318 Skin Sympathetic Nerve Activity as a Potential Diagnostic Biomarker for Differentiating Detrusor Overactivity, Hypersensitive Bladder, and Bladder Pain Syndrome
04-23
#0296 A Novel Approach to Bladder Dysfunction induced by Bladder Outlet Obstruction: Low-Intensity Extracorporeal Shock Wave Therapy Promotes Bladder Regeneration
04-23
#0223 Linking LUTS and heart health: exploring the cardiac implications of urinary symptoms
04-23
#0223 Linking LUTS and heart health: exploring the cardiac implications of urinary symptoms
04-23
#0204 Multichannel Urodynamic Study for Prediction in Initial Trial Without Catheter Failure After Prostate Deobstruction Surgery
04-23
#0124 An investigation into the relationship between program control frequency and satisfaction assessment subsequent to sacral neuromodulation, devising an optimal selection of programming control mode for patients
04-23
#0123 Optimization of Sacral Neuromodulation Therapy: Clinical Outcomes and Patient Suitability Exploration of Variable Frequency Mode: A prospective multi-center study
04-23
#0122 The efficacy and safety of sacral neuromodulation with variable frequency stimulation mode compared with constant frequency stimulation mode in the treatment of refractory lower urinary tract dysfunction - a multicenter, prospective, randomized, do
04-23
<
11
12
13
14
15
16
17
18
19
20
>
/ 155